Adtec visits Taiwan for SteriPlas expansion project
Who better to facilitate the expansion of the SteriPlas Premium Cold Plasma in the SE Asia market but the leading medical distributor, SG Biomedical. Adtec Healthcare Limited joins SG Biomedical in Taiwan to complete the introduction of three SteriPlas medical devices in the leading wound care hospitals.
Over 30 patients have so far been treated ranging from Diabetic Foot Ulcers, LVAD infections, Burn wounds, Vascular and Orthopaedic wounds and so on. All patients have had chronic infection with biofilm prior to being introduced to the SteriPlas. Some wounds have been non-healing for 4 years!
We are happy to report that over continued twice weekly use over the last two months, all patients are responding very well with most having been fully healed and no relapse of infection.
If you are within the Taiwan region and you are interested to learn more, please contact us so that we may introduce you to our partner.
First day at the LSI
An epic start to the first day at LSI - Life Science Intelligence in Barcelona.
It has been a pleasure to interact with professionals sharing the same interest in tackling strains on the global wound care market. The benefits that the clinically proven SteriPlas can bring to significantly reduce bed occupancy, chronic infections and the financial burden rates have been demonstrated.
We look forward to presenting more about this on the 21st Sept and encourage you to meet with us whilst at LSI to learn more about our Premium Cold Plasma medical device for chronic wounds, surgical site infections and medical dermatology conditions.